However, under conditions of hypoxia or chemotherapy-induced ROS accumulation, low expression of YTHDF1 in NSCLC can reduce the translation of keap, promote the upregulation of Nrf2 and its downstream antioxidant AKR1C1, and induce cisplatin resistance [215]. Here, YTHDF1 is linked to non-small cell lung carcinoma.